Is VCYT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VCYT. It does not provide personalized investment advice.

VCYT (Veracyte, Inc.) Stock Analysis - Financials

Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of July 15, 2026, VCYT trades at $57.20 with a market cap of $4.59B and a P/E ratio of 50.86. VCYT moved +1.02% today. Year to date, VCYT is +34.49%; over the trailing twelve months it is +112.46%. Its 52-week range spans $22.61 to $60.91. Analyst consensus is buy with an average price target of $55.43. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are VCYT's key financials?

VCYT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VCYT recently traded at $57.20. Market cap is $4.59B. P/E ratio is 50.86. Revenue is $541.74M.

VCYT Key Metrics

Key financial metrics for VCYT
Metric	Value
Price	$57.20
Market Cap	$4.59B
P/E Ratio	50.86
EPS	$1.11
Dividend Yield	0.00%
52-Week High	$60.91
52-Week Low	$22.61
Volume	1.59K
Avg Volume	0
Revenue (TTM)	$541.74M
Net Income	$88.01M
Gross Margin	70.92%

VCYT Analyst Consensus

9 analysts cover VCYT: 0 strong buy, 7 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $55.43.

Common questions about VCYT

What are VCYT's key financials?: VCYT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VCYT recently traded at $57.20. Market cap is $4.59B. P/E ratio is 50.86. Revenue is $541.74M.
Is VCYT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VCYT. It does not provide personalized investment advice.